Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02152020 · ClinicalTrials.gov registry record
Patient-Centered Acupuncture for Pain (PCAP)
A clinical trial, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- 36
- Enrollment target
NCT02152020 is a clinical trial that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 36 participants.
The verdict
NCT02152020 has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- 36 participants
- Enrollment target
Study Summary
The objective of this study is to find out if acupuncture can improve the management of pain in cancer patients when used as part of a treatment plan that includes conventional pain medications. The investigators will enroll 36 cancer patients at Abramson Cancer Center and Penn Cancer Network sites. Participants will be enrolled in either the Conventional Pain Management group or Integrative Pain Management group.
Interventions
- BEHAVIORAL Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2014-05 |
| Est. Completion | 2015-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02152020
The ClinicalTrials.gov registry entry for NCT02152020 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Survey is the first listed.
NCT02152020 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02152020 about?
NCT02152020 is a clinical study titled "Patient-Centered Acupuncture for Pain (PCAP)". The objective of this study is to find out if acupuncture can improve the management of pain in cancer patients when used as part of a treatment plan that includes conventional pain medications. The investigators will enroll 36 cancer patients at Abramson Cancer Center and Penn Cancer Network sites....
What is the current status of trial NCT02152020?
This trial is currently completed. The enrollment target is 36 participants. The study started on 2014-05. Estimated completion is 2015-01.
What interventions are being tested in trial NCT02152020?
The interventions under investigation include: Survey (BEHAVIORAL).
Who is sponsoring clinical trial NCT02152020?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.